The BIVDA Market Audit for the year 2025 has been completed and results distributed to participating companies.
The top line growth of UK IVD industry revenues of 3.9% shows recovery from the post-Covid effect with some stronger growth in specific areas, and the total, adjusted (using government figures for glucose test strip revenues) is just over £1.2 billion from the 25 companies participating, which we estimate to represent 95% of the total UK clinical market.
A summary report is available to participants on request to John Bagshaw (johnalbagshaw@btinternet.com).
If you don’t take part and would like to know more, please contact John who will be pleased to talk you through the benefits.
